Fengchuan Capital
Overview
Fengchuan Capital is a private equity investment fund established in 2015, focusing on investments in the life sciences and healthcare industries, including innovative biopharmaceuticals, medical devices, and medical services.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Degron Therapeutics | - | Series A | Co-investor |
| Beijing WellGene Biotech Co., Ltd. | May 2023 | Series C | Co-investor |
| 4B Technologies | Feb 2021 | Series A Extension | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Fengchuan Capital based?
Fengchuan Capital is headquartered in Beijing, China.
When was Fengchuan Capital founded?
Fengchuan Capital was founded in 2015.
How many portfolio companies does Fengchuan Capital have?
Fengchuan Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in Fengchuan Capital's portfolio?
Portfolio companies visible on Caplight include Degron Therapeutics, Beijing WellGene Biotech Co., Ltd., 4B Technologies.
What was Fengchuan Capital's most recent investment shown here?
Fengchuan Capital's most recent investment in this portfolio sample was in Beijing WellGene Biotech Co., Ltd. in 2023.
What sectors does Fengchuan Capital focus on?
Fengchuan Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Fengchuan Capital focus on?
Fengchuan Capital typically invests at the Early stage.